Luis Pareras

Degree and PhD in Medicine (UB), specialist in Neurosurgery and Global Executive MBA (IESE).

Founding Partner of two Venture Capital funds (Healthequity and Invivo Ventures) focused in early-stage investments in the healthcare sector, where he has led the investment strategy and transaction processes.

He serves or has served at the Board of Directors of many life-sciences companies including Sanifit, Minoryx, Versantis, Glycardial Diagnostics, n-Life Therapeutics, Peptomyc, Arthex, Pulmobiotics, Gyala, Telum, OneChain Immunotherapeutics, Telomere Therapeutics Corteria and Integra.

Deeply involved in the innovation ecosystem, he is a member and advisor of many healthcare innovation organizations, and author of numerous books in the field of innovation, venture capital and healthcare.

In the academic space, he teaches at several business schools about healthcare innovation and venture capital.

He founded the managing company Invivo Partners together with Albert Ferrer.